BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis B
1
From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
9/17/2026 5:48:20 AM | Browse: 29 | Download: 69
2
Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration
9/7/2026 2:26:33 AM | Browse: 41 | Download: 85
3
Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B
9/1/2026 6:22:40 AM | Browse: 30 | Download: 70
4
Routine laboratory model for identifying significant fibrosis in chronic hepatitis B
6/26/2026 9:50:21 AM | Browse: 56 | Download: 207
5
Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines
6/26/2026 9:50:19 AM | Browse: 40 | Download: 187
6
Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B
6/18/2026 7:52:55 AM | Browse: 57 | Download: 206
7
Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B
5/29/2026 7:26:46 AM | Browse: 55 | Download: 301
8
Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology
5/26/2026 3:52:09 AM | Browse: 41 | Download: 166
9
Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study
5/26/2026 3:52:08 AM | Browse: 63 | Download: 244
10
Why does hepatitis B remain underprioritized? A view through lived experience
4/23/2026 11:05:50 AM | Browse: 99 | Download: 334
11
Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study
3/19/2026 7:07:29 AM | Browse: 94 | Download: 397
12
Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation
2/12/2026 11:20:21 AM | Browse: 136 | Download: 575
13
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
2/12/2026 11:20:19 AM | Browse: 139 | Download: 578
14
Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey
12/25/2025 9:13:55 AM | Browse: 114 | Download: 496
15
Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B
11/28/2025 3:10:38 AM | Browse: 300 | Download: 631
16
Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B
11/4/2025 2:41:47 AM | Browse: 314 | Download: 760
17
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 434 | Download: 611
18
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
10/24/2025 7:36:34 AM | Browse: 356 | Download: 554
19
Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B
10/24/2025 7:36:26 AM | Browse: 219 | Download: 465
20
Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies
9/26/2025 8:18:47 AM | Browse: 566 | Download: 577
21
Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report
9/25/2025 11:24:05 AM | Browse: 188 | Download: 584
22
Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years
9/25/2025 11:24:00 AM | Browse: 423 | Download: 537
23
Chronic hepatitis B: Is it time for expanded antiviral treatment?
9/25/2025 9:22:03 AM | Browse: 282 | Download: 433
24
Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics
7/25/2025 12:09:41 PM | Browse: 302 | Download: 714
25
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 314 | Download: 1053
26
Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B
7/4/2025 9:23:52 AM | Browse: 220 | Download: 975
27
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 374 | Download: 1166
28
Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease
5/27/2025 7:04:47 AM | Browse: 326 | Download: 974
29
Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients
3/13/2025 10:11:05 AM | Browse: 286 | Download: 938
30
Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment
2/26/2025 4:21:35 AM | Browse: 282 | Download: 688
31
CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment
12/20/2024 3:53:46 AM | Browse: 113 | Download: 561
32
Current status of drug therapy for chronic hepatitis B
12/18/2024 7:36:02 AM | Browse: 335 | Download: 909
33
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 389 | Download: 1089
34
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 382 | Download: 1369
35
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
11/12/2024 6:08:07 AM | Browse: 190 | Download: 1221
36
Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action
11/6/2024 9:50:59 AM | Browse: 309 | Download: 1057
37
Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway
10/31/2024 10:42:49 AM | Browse: 359 | Download: 955
38
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
10/21/2024 7:03:25 AM | Browse: 359 | Download: 861
39
Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
7/26/2024 10:33:30 AM | Browse: 382 | Download: 1178
40
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
7/26/2024 10:33:30 AM | Browse: 449 | Download: 1713
41
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients
7/9/2024 2:00:35 PM | Browse: 308 | Download: 825
42
Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
6/25/2024 10:41:21 AM | Browse: 415 | Download: 841
43
Hepatitis B cure: Current situation and prospects
6/20/2024 3:42:22 AM | Browse: 374 | Download: 1063
44
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
6/20/2024 3:42:22 AM | Browse: 241 | Download: 1408
45
Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy
3/27/2024 1:28:19 PM | Browse: 406 | Download: 1512
46
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
3/11/2024 2:44:49 PM | Browse: 519 | Download: 1546
47
Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis
3/6/2024 6:10:52 AM | Browse: 494 | Download: 1388
48
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 562 | Download: 1831
49
Antiviral treatment standards for hepatitis B: An urgent need for expansion
1/26/2024 7:56:29 AM | Browse: 610 | Download: 1446
50
Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
12/6/2023 8:08:49 AM | Browse: 578 | Download: 1661
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.